| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/12/2002 | EP1212336A2 Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms |
| 06/12/2002 | EP1212328A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 06/12/2002 | EP1212295A1 SUBSTITUTED $g(a)-HYDROXY ACID CASPASE INHIBITORS AND THE USE THEREOF |
| 06/12/2002 | EP1212191A1 Method and device for producing tablets |
| 06/12/2002 | EP1212144A1 Aerosol airflow control system and method |
| 06/12/2002 | EP1212120A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 06/12/2002 | EP1212117A1 Container for receiving a pharmaceutical agent which acts upon or via the skin |
| 06/12/2002 | EP1212099A2 Amphiphilic prodrugs |
| 06/12/2002 | EP1212095A2 Process to make a sustained release formulation |
| 06/12/2002 | EP1212093A2 Use of emu oil as a carrier for antifungal, antibacterial and antiviral medications |
| 06/12/2002 | EP1212092A2 High viscosity liquid controlled delivery system and medical or surgical device |
| 06/12/2002 | EP1212091A2 Polyoxyalkylene copolymers containing pourable liquid vehicles |
| 06/12/2002 | EP1212089A2 Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonists |
| 06/12/2002 | EP1212086A1 Immunological tolerance-induction agent |
| 06/12/2002 | EP1212085A2 Compositions for stimulating cytokine secretion and inducing an immune response |
| 06/12/2002 | EP1212084A2 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 06/12/2002 | EP1212080A2 The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
| 06/12/2002 | EP1212079A1 Topical treatment of streptococcal infections |
| 06/12/2002 | EP1212077A2 Pharmaceutical composition of nateglinide and another antidiabetic agent |
| 06/12/2002 | EP1212076A2 Stimulation of sperm function |
| 06/12/2002 | EP1212071A1 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 06/12/2002 | EP1212069A2 Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
| 06/12/2002 | EP1212063A2 Topical azathioprine for the treatment of oral autoimmune diseases |
| 06/12/2002 | EP1212061A1 Injectable buprenorphine microparticle compositions and their use in reducing consumption of heroin and alcohol |
| 06/12/2002 | EP1212058A1 Topical treatment for prevention of ocular infections |
| 06/12/2002 | EP1212050A2 Formulations containing tetracyclinesfor treating or preventing mucositis |
| 06/12/2002 | EP1212046A2 Flushable disposable polymeric products |
| 06/12/2002 | EP1212045A1 A vaccine composition and method of using the same |
| 06/12/2002 | EP1212044A2 Method for coating pharmaceutical dosage forms |
| 06/12/2002 | EP1212043A2 Composition to be administered through mucous membrane |
| 06/12/2002 | EP1212041A1 Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
| 06/12/2002 | EP1212039A1 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent |
| 06/12/2002 | EP1212020A1 Disposable thermal body wrap |
| 06/12/2002 | EP1211951A1 Process for manufacturing a pharmaceutical chewing gum |
| 06/12/2002 | EP1211942A1 Method for the production of polyvinylpyrrolidone-iodine in an aqueous solution |
| 06/12/2002 | EP1139773A4 Controlling release of active agents from a chewing gum coating |
| 06/12/2002 | EP1082107A4 Controlled release lipoic acid |
| 06/12/2002 | EP1061920B1 Pharmaceutical formulation comprising a 2[[(2-pyridinyl)methyl]sulfinyl]benzimidazole having anti-ulcer activity and a process for the preparation of such formulation |
| 06/12/2002 | EP1005391B1 Process and apparatus for preparation of vesicles |
| 06/12/2002 | EP0977484A4 Non-spherical and non-platelet pyrithione salts |
| 06/12/2002 | EP0948357B1 Use of low molecular weight amino alcohols in ophthalmic compositions |
| 06/12/2002 | EP0939655B1 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 06/12/2002 | EP0938467B1 Process for the preparation of optically pure isomers of formoterol |
| 06/12/2002 | EP0935459B1 Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix |
| 06/12/2002 | EP0934080B1 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof |
| 06/12/2002 | EP0932360B1 Biocide impregnated fibre reinforced sponge material |
| 06/12/2002 | EP0855913B1 Iron dextran formulations |
| 06/12/2002 | EP0813407B1 Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate |
| 06/12/2002 | EP0802800B1 Biocompatible immunoisolatory capsules containing genetically altered cells for the delivery of biologically active molecules |
| 06/12/2002 | EP0788505B1 Poly-unsaturated carbohydrate derivatives, polymers thereof and their use |
| 06/12/2002 | EP0751778B1 Use of deuterium-depleted water for preparing hygienic and cosmetic preparations |
| 06/12/2002 | EP0697881B1 New cyclosporine-containing pharmaceutical compositions for oral administration |
| 06/12/2002 | EP0689427B1 Water dispersible therapeutic carotenoid compounds |
| 06/12/2002 | EP0688211B1 Thalidomide for inhibition of angiogenesis |
| 06/12/2002 | EP0678035B1 Vaccine preparations |
| 06/12/2002 | CN1353720A Process for making cellulose ethers having reduced yellowing and discoloration |
| 06/12/2002 | CN1353699A Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 06/12/2002 | CN1353615A Compositions of A-beta peptide and processes for producing same |
| 06/12/2002 | CN1353613A Pharmaceutical compositions |
| 06/12/2002 | CN1353611A Balsam for treatment of surface burns and chafing rashes |
| 06/12/2002 | CN1353610A Medicinal composition for oral administration |
| 06/12/2002 | CN1353607A Improved pharmaceutical formulations |
| 06/12/2002 | CN1353596A Method and device for producing product made of strip tape, especially medical product and/or product containing active substances as well as fillable receptacles or pouches whose edges can be sealed |
| 06/12/2002 | CN1353581A Method and composition for masking mineral taste |
| 06/12/2002 | CN1353573A Anti-inflammatory therapy for inflammatory mediated infection |
| 06/12/2002 | CN1352989A Medical wine 'Sansan' for treating hyperosteogeny |
| 06/12/2002 | CN1352985A Active component of red sage root, its slowly releasing medicine and medical purpose, and its preparing process |
| 06/12/2002 | CN1352984A Chinese medicine for treating baby's congenital heart disease |
| 06/12/2002 | CN1352983A Chinese medicine for treating hypertension |
| 06/12/2002 | CN1352980A Medicine for treating hemicrania and its preparing process |
| 06/12/2002 | CN1352972A Health-care Fuchunkang series |
| 06/12/2002 | CN1352969A Universal surgical plaster |
| 06/12/2002 | CN1352963A Blood pressure stabilizing pill |
| 06/12/2002 | CN1352956A Chinese-medicinal spray for treating chronic pharyngolaryngitis and its preparing process |
| 06/12/2002 | CN1352944A Jixitabin solution preparation |
| 06/12/2002 | CN1352938A Slowly releasing bupropion hydrochloride tablet |
| 06/12/2002 | CN1352937A Dispersed calcium carbonate-xylitol solid and chewing compound calcium carbonate tablet |
| 06/12/2002 | CN1086129C Medicine for treating hepatitis |
| 06/12/2002 | CN1086127C Suppository for treating prostate disease |
| 06/12/2002 | CN1086125C Externally used medicine for treating tinea |
| 06/12/2002 | CN1086124C Shuangzuoxing suppository |
| 06/12/2002 | CN1086123C Low-viscosity cosmetic and pharmaceutical emulsions |
| 06/12/2002 | CA2364730A1 Lipids comprising an aminoxy group |
| 06/12/2002 | CA2364392A1 Compound |
| 06/12/2002 | CA2362898A1 Method of dispensing a formula with medical or nutritional preparations in the form of initially-reduced-release particles (irrp) |
| 06/11/2002 | US6403758 Bioresorbable compositions for implantable prostheses |
| 06/11/2002 | US6403700 Crosslinked, hydrophilic homopolymers, copolymers, or graft polymers of ethylenically unsaturated, acid group-containing neutralized salt monomers; diapers |
| 06/11/2002 | US6403672 Preparation and use of photopolymerized microparticles |
| 06/11/2002 | US6403655 Method of preventing adhesions with absorbable polyoxaesters |
| 06/11/2002 | US6403654 Compositions for and method of treatment for psoriasis |
| 06/11/2002 | US6403635 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 06/11/2002 | US6403634 For treating abnormal cell proliferation |
| 06/11/2002 | US6403619 Method for controlling cell necrosis or apoptosis |
| 06/11/2002 | US6403618 Administering picolinic acid derivatives to chelate with zinc and iron in proteins; antiangiogenic and antineoplastic agent |
| 06/11/2002 | US6403616 Chemical process and pharmaceutical formulation |
| 06/11/2002 | US6403609 Topical-use lubricant that gels when administered to the eye |
| 06/11/2002 | US6403597 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
| 06/11/2002 | US6403590 Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia |
| 06/11/2002 | US6403579 Treating cardiac and cardiovascular disorders and the illnesses associated therewith, hypertension, angina pectoris, cardiac insufficiency |
| 06/11/2002 | US6403565 Enhances dna repair and prevents consequences of mutagenic radiation even when administered after damage or exposure to radiation has already occurred; deoxyribonucleosides: deoxycytidine, deoxyadenosine, deoxyguanosine, and thymidine. |